ISTH 2025: Sutacimig - A Novel Prophylactic Treatment for Glanzmann Thrombasthenia: Interim Analysis of a Phase 1/2 Study
Presented at the ISTH (International Society on Thrombosis and Haemostasis) 2025 Congress
To view the presentation, click here
Presented at the ISTH (International Society on Thrombosis and Haemostasis) 2025 Congress
To view the presentation, click here